Amino acid-based enteral nutrition is effective for pediatric Crohn's disease: a multicenter prospective study.

Authors:
Yang Q; Zhang T; Diao N; Chao K; Shu H and 6 more

Journal:
Gastroenterol Rep (Oxf)

Publication Year: 2023

DOI:
10.1093/gastro/goad072

PMCID:
PMC10746840

PMID:
38143506

Journal Information

Full Title: Gastroenterol Rep (Oxf)

Abbreviation: Gastroenterol Rep (Oxf)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest Shenzhen Wanhe Pharmaceutical Co., Ltd (Shenzhen, P. R. China) funded this study by providing Elental. No honoraria or payments were made for authorship. All authors had access to the relevant data and participated in the drafting, review, and approval of this submission. The authors declare that there is no other conflict of interest regarding the publication of this paper."

Evidence found in paper:

"Funding This work was supported by the Guangdong Provincial Key Laboratory of Microecological Preparations [grant number 2022B1212020004], the Medical Scientific Research Foundation of Guangdong Province of China [grant number A2022099], and the program of Guangdong Provincial Clinical Research Center for Digestive Diseases [grant number 2020B1111170004]."

Evidence found in paper:

"This multicenter, prospective study was conducted between March 2019 and December 2021, and patients were recruited from four large hospitals in Guangdong, Beijing, and Shanghai (). The study adhered to the ethical principles of the Declaration of Helsinki and Good Clinical Practice guidelines. Patients or their parents/legal representatives provided written informed consent. The study protocol was approved by the Institutional Review Boards of the four hospitals. This trial was registered with the Chinese Clinical Trial Registry (registration number 1900026979)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025